Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanping Zhou

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
International Journal of Clinical and Experimental Pathology|January 15, 2020
AFP specificity for HCC surveillance is increased by mitigating liver injury among treated chronic hepatitis B patients with elevated AFPGuosheng Yuan, Yuchen Zhou, Junwei Liu, et al.
British Journal of Clinical Pharmacology|May 17, 2017
A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective studyGuosheng Yuan, Chengguang Hu, Yuchen Zhou, et al.
Clinical Therapeutics|January 31, 2021
Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients With Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world ExperienceChengguang Hu, Yangda Song, Cuirong Tang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 27, 2017
Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Guangzhou, China: Predominance of Genotype 1b and Increasing Incidence of Genotype 6aGuosheng Yuan, Junwei Liu, Chengguang Hu, et al.
Emerging Microbes & Infections|August 9, 2018
Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargementXiaobing Duan, Muhammad Ikram Anwar, Zhanxue Xu, et al.
Scientific Reports|February 24, 2026
Development of a CT radiomics and clinical feature combined model for predicting early recurrence of surgical resected hepatocellular carcinomaMinjun Liao, Naying Liao, Shengjun Huo, et al.
Pharmacological Research|December 3, 2024
Integrative radiomics analyses identify universal signature for predicting prognosis and therapeutic vulnerabilities across primary and secondary liver cancers: A multi-cohort studyHongjie Xin, Qianwei Lai, Yanping Liu, et al.
Frontiers in Cellular and Infection Microbiology|September 1, 2021
Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected PatientsYuanhao Liang, Fengyu Hu, Hang Fan, et al.
Molecular Medicine Reports|March 22, 2019
Serum‑derived hepatitis C virus can infect human glioblastoma cell line SF268 and activate the PI3K‑Akt pathwayGuosheng Yuan, Liang Rong, Junwei Liu, et al.
Plos One|May 17, 2019
Logistic regression prediction model identify type 2 diabetes mellitus as a prognostic factor for human papillomavirus-16 associated head and neck squamous cell carcinomaAastha Sobti, Fatemeh Saheb Sharif-Askari, Saif Khan, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Clinical and Experimental Pathology|January 15, 2020
AFP specificity for HCC surveillance is increased by mitigating liver injury among treated chronic hepatitis B patients with elevated AFPGuosheng Yuan, Yuchen Zhou, Junwei Liu, et al.
British Journal of Clinical Pharmacology|May 17, 2017
A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective studyGuosheng Yuan, Chengguang Hu, Yuchen Zhou, et al.
Clinical Therapeutics|January 31, 2021
Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients With Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world ExperienceChengguang Hu, Yangda Song, Cuirong Tang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 27, 2017
Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Guangzhou, China: Predominance of Genotype 1b and Increasing Incidence of Genotype 6aGuosheng Yuan, Junwei Liu, Chengguang Hu, et al.
Emerging Microbes & Infections|August 9, 2018
Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargementXiaobing Duan, Muhammad Ikram Anwar, Zhanxue Xu, et al.
Scientific Reports|February 24, 2026
Development of a CT radiomics and clinical feature combined model for predicting early recurrence of surgical resected hepatocellular carcinomaMinjun Liao, Naying Liao, Shengjun Huo, et al.
Pharmacological Research|December 3, 2024
Integrative radiomics analyses identify universal signature for predicting prognosis and therapeutic vulnerabilities across primary and secondary liver cancers: A multi-cohort studyHongjie Xin, Qianwei Lai, Yanping Liu, et al.
Frontiers in Cellular and Infection Microbiology|September 1, 2021
Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected PatientsYuanhao Liang, Fengyu Hu, Hang Fan, et al.
Molecular Medicine Reports|March 22, 2019
Serum‑derived hepatitis C virus can infect human glioblastoma cell line SF268 and activate the PI3K‑Akt pathwayGuosheng Yuan, Liang Rong, Junwei Liu, et al.
Plos One|May 17, 2019
Logistic regression prediction model identify type 2 diabetes mellitus as a prognostic factor for human papillomavirus-16 associated head and neck squamous cell carcinomaAastha Sobti, Fatemeh Saheb Sharif-Askari, Saif Khan, et al.
Pageof 9